All the patients described herein and diagnosed with myeloid neoplasms are selected cases in which we had failed to detect variants in the genes commonly mutated in familial myeloid neoplasms (such as CEBPA, RUNX1, GATA2, DDX41, ANKRD26, etc.)[17]. This evidence concerns the gene RUNX1 and myeloid neoplasm.